StrokeSeg2: Stroke Lesion Segmentation in Clinical Research Workflows

Deep learning frameworks like nnU-Net achieve state-of-theart brain lesion segmentation performance but remain difficult to deploy in clinical research environments due to, among other reasons, software dependencies and computational requirements. We introduce StrokeSeg2, a lightweight, modular, cross-platform C++/Qt framework designed to adapt resource-intensive 3D stroke segmentation pipelines into portable and reproducible applications. To improve compatibility with standard clinical workstations, we investigate the combined effect of architectural compression through knowledge distillation and inference optimisation using ONNX Runtime with Float16 quantisation. Across heterogeneous hardware configurations (CPU, integrated GPU, and dedicated GPU) architectural distillation emerged as the primary contributor to efficiency gains, contributing to over 90% reduction in energy consumption and an average 84% reduction in inference time. Specifically, we identify a 0.84M-parameter student model as the most favourable trade-off, reducing the original 102.3M-parameter teacher architecture to a 2.1 MB disk footprint while preserving robust lesion localisation and competitive segmentation performance. This small footprint supports the development of a self-contained installer for clinical workstation targets. Finally, StrokeSeg2 packages these optimisations into standalone installers for Windows, macOS, and Linux. By providing both graphical and commandline interfaces without Docker or external environment dependencies, StrokeSeg2 facilitates deployment of high-performance segmentation workflows for routine clinical research pipelines.

Unsupervised Deep Generative Models for Anomaly Detection in Neuroimaging: A Systematic Scoping Review

Unsupervised deep generative models are emerging as a promising alternative to supervised methods for detecting and segmenting anomalies in brain imaging. Unlike fully supervised approaches, which require large voxel-level annotated datasets and are limited to well-characterised pathologies, these models can be trained exclusively on healthy data and identify anomalies as deviations from learned normative brain structures. This PRISMA-guided scoping review synthesises recent work on unsupervised deep generative models for anomaly detection in neuroimaging, including autoencoders, variational autoencoders, generative adversarial networks, and denoising diffusion models. A total of 49 studies published between 2018 - 2025 were identified, covering applications to brain MRI and, less frequently, CT across diverse pathologies such as tumours, stroke, multiple sclerosis, and small vessel disease. Reported performance metrics are compared alongside architectural design choices. Across the included studies, generative models achieved encouraging performance for large focal lesions and demonstrated progress in addressing more subtle abnormalities. A key strength of generative models is their ability to produce interpretable pseudo-healthy (also referred to as counterfactual) reconstructions, which is particularly valuable when annotated data are scarce, as in rare or heterogeneous diseases. Looking ahead, these models offer a compelling direction for anomaly detection, enabling semi-supervised learning, supporting the discovery of novel imaging biomarkers, and facilitating within- and cross-disease deviation mapping in unified end-to-end frameworks. To realise clinical impact, future work should prioritise anatomy-aware modelling, development of foundation models, task-appropriate evaluation metrics, and rigorous clinical validation.